Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephropathy

Annals of Internal Medicine

Volumn 148, Issue 4, 2008, Pages 284-294

  Kelly, Aine M ^a,b,c   Dwamena, Ben ^a,c   Cronin, Paul ^a,c   Bernstein, Steven J ^a,c   Carlos, Ruth C ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMINOPHYLLINE; BICARBONATE; DOPAMINE; FENOLDOPAM; FUROSEMIDE; ILOPROST; IODINATED CONTRAST MEDIUM; MANNITOL; SIMVASTATIN; THEOPHYLLINE; ASCORBIC ACID; CONTRAST MEDIUM; PROTECTIVE AGENT;

CLINICAL TRIAL; CONTRAST MEDIUM INDUCED NEPHROPATHY; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; HIGH RISK PATIENT; HUMAN; HYDRATION; KIDNEY DISEASE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZATION; RENAL PROTECTION; REVIEW; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; ACUTE KIDNEY FAILURE; ARTICLE; CHEMICALLY INDUCED DISORDER; METHODOLOGY; STANDARD;

ACETYLCYSTEINE; ASCORBIC ACID; BICARBONATES; CLINICAL TRIALS AS TOPIC; CONTRAST MEDIA; FUROSEMIDE; KIDNEY FAILURE, ACUTE; PROTECTIVE AGENTS; RESEARCH DESIGN; THEOPHYLLINE;

EID: 40049091486     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-148-4-200802190-00007     Document Type: Review

References (68)